Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NLS Pharmaceutics Ltd. - Common Shares (NQ:NLSP)

2.320 -0.120 (-4.91%)
Streaming Delayed Price Updated: 12:49 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 97,258
Open 2.450
Bid (Size) 2.320 (3)
Ask (Size) 2.340 (2)
Prev. Close 2.440
Today's Range 2.310 - 2.470
52wk Range 1.300 - 15.59
Shares Outstanding 32,428,893
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Wednesday's pre-market session
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted stronger-than-expected results for the third quarter. The company posted... 
Via Benzinga

Performance

YTD
+6.4%
+6.4%
1 Month
+0.9%
+0.9%
3 Month
+63.4%
+63.4%
6 Month
+11.0%
+11.0%
1 Year
-67.7%
-67.7%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
What's Going On With NLS Pharmaceutics Shares Monday?
Via Benzinga
Unusual volume stocks in Wednesday's session
Via Chartmill
Which stocks have an unusual volume on Friday?
Via Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
What's Going On With NLS Pharmaceutics Shares Monday?
Via Benzinga
NLS Pharmaceutics and Kadimastem Announces Up to $3 Million Equity Financing and $25 Million Equity Facility Agreement
Via ACCESS Newswire
Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment
Via News Direct
Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
The market is filled with gapping stocks in Monday's session.
Via Chartmill
Monday's pre-market session: top gainers and losers
Via Chartmill
Which stocks are most active on Friday?
Via Chartmill
Dow Edges Lower; Exxon Mobil Earnings Top Views
Via Benzinga
Topics Stocks
What's Going On With NLS Pharmaceutics Stock Friday?
Via Benzinga
Which stocks are gapping on Friday?
Via Chartmill
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
What's going on in today's after hours session
Via Chartmill
What's Going On With NLS Pharmaceuticals Stock Monday?
Via Benzinga
Topics Regulatory Compliance
NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment
Via ACCESSWIRE
NLS Pharmaceutics CEO Issues Letter to Shareholders
Via ACCESSWIRE
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
Via ACCESSWIRE
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
Via ACCESSWIRE

Frequently Asked Questions

Is NLS Pharmaceutics Ltd. - Common Shares publicly traded?
Yes, NLS Pharmaceutics Ltd. - Common Shares is publicly traded.
What exchange does NLS Pharmaceutics Ltd. - Common Shares trade on?
NLS Pharmaceutics Ltd. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NLS Pharmaceutics Ltd. - Common Shares?
The ticker symbol for NLS Pharmaceutics Ltd. - Common Shares is NLSP on the Nasdaq Stock Market
What is the current price of NLS Pharmaceutics Ltd. - Common Shares?
The current price of NLS Pharmaceutics Ltd. - Common Shares is 2.320
When was NLS Pharmaceutics Ltd. - Common Shares last traded?
The last trade of NLS Pharmaceutics Ltd. - Common Shares was at 07/07/25 12:49 PM ET
What is the market capitalization of NLS Pharmaceutics Ltd. - Common Shares?
The market capitalization of NLS Pharmaceutics Ltd. - Common Shares is 75.24M
How many shares of NLS Pharmaceutics Ltd. - Common Shares are outstanding?
NLS Pharmaceutics Ltd. - Common Shares has 75M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.